VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
SPRY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
SPRYARS Pharmaceuticals, Inc.
$3.69$366M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksSPRYQuarterly Balance Sheet

ARS Pharmaceuticals, Inc. (SPRY) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

ARS Pharmaceuticals, Inc. (SPRY) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

SPRY Balance Sheet

Quarterly statement

SPRY Balance Sheet

ARS Pharmaceuticals, Inc. (SPRY) balance sheet — 8-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Total Current Assets211.03M211.51M245.24M284.9M338.86M281.44M303.86M334.3M208.79M220.74M226.24M231.56M244.47M255.03M267.35M277.7M39.09M45.39M261.33M60.73M
Cash & Short-Term Investments138.35M143.84M200.97M244.99M288.21M240.13M275.73M314.02M204.62M218.74M223.63M228.36M241.9M252.21M264.55M274.38M37.32M44.59M253.85M60.06M
Cash Only25.62M8.16M24.32M41.32M59.56M51.54M39.86M50.82M39.66M36.63M56.01M70.97M60.53M119.02M87.86M210.52M37.32M44.59M233.99M60.06M
Short-Term Investments112.73M135.68M176.65M203.67M228.65M188.59M235.86M263.2M164.97M182.12M167.63M157.39M181.37M133.19M176.69M63.86M0019.86M0
Accounts Receivable52.76M46.84M29.46M26.35M37.69M26.08M10.27M9.16M1.24M542K618K795K814K0522K0035K01K
Days Sales Outstanding121.49103.15110.73104.8890.26105.25109.75.5339.62105.56----2.35K--6.86-0.12
Inventory11.71M11.69M8.82M8.37M7.78M8.74M7.27M5.21M715K00000000000
Days Inventory Outstanding-72.63123.03232.0392.78146.14138.8370.05587.32-----------
Other Current Assets8.21M05.99M5.19M1.35M2.03M963K1.23M593K323K300K00962K01.01M1.18M07.49M0
Total Non-Current Assets40.46M37.98M42.34M42.76M33.94M32.04M23.46M16.86M8.81M1.23M1.34M1.63M4.09M3.72M3.84M3.73M637K661K51.14M716K
Property, Plant & Equipment1.93M2.08M2.29M2.46M2.65M2.64M1.15M1.07M935K782K814K824K917K943K982K774K615K638K6.91M693K
Fixed Asset Turnover18.80x15.40x9.55x10.99x12.29x8.30x7.21x86.54x2.41x0.63x---0.01x0.02x-0.30x0.12x0.17x0.20x
Goodwill00000000000000000000
Intangible Assets13.62M13.9M14.18M14.45M14.73M13.16M7.49M7.68M7.88M446K528K000000000
Long-Term Investments00000000000000000044.22M0
Other Non-Current Assets24.91M22M25.87M25.84M16.56M16.24M14.82M8.11M000801K3.17M2.77M2.86M2.96M22K23K023K
Total Assets251.48M249.5M287.57M327.65M372.8M313.47M327.32M351.15M217.6M221.97M227.58M233.19M248.56M258.75M271.19M281.44M39.73M46.05M312.47M61.45M
Asset Turnover0.15x0.13x0.07x0.08x0.09x0.05x0.02x0.30x0.01x0.00x---0.00x0.00x-0.00x0.00x0.00x0.00x
Asset Growth %-32.54%-20.41%-12.14%-6.69%71.32%41.23%43.82%50.59%-12.45%-14.22%-16.08%-17.14%525.58%461.91%-13.21%358.02%-88.73%-87.45%-18.24%-
Total Current Liabilities64.9M60.86M49.61M39.15M50.88M45.6M27.62M23.44M16.62M6.72M3.71M2.39M11.18M10.05M9.84M5.44M8.33M7.46M14.81M8.19M
Accounts Payable059.73M4.71M5.72M8.38M15.56M4.09M9.87M8.28M3.27M839K759K2.97M1.5M2.58M1.66M2.46M1.94M2.63M1.79M
Days Payables Outstanding-228.2374.67202.66134.45179.43155.32214.474.74K27.1213.8950.3468.4525.7629.5753.3553.3647.7836.6541.2
Short-Term Debt0000583K000000237K235K0232K03.52M3.5M1.12M3.48M
Deferred Revenue (Current)0535K757K609K0746K540K557K00000010K00344K01.46M
Other Current Liabilities64.9M596K592K588K41.91M4.31M4.73M2.29M2.58M1.5M1.07M1.08M5.83M278K5.83M1.46M844K472K11.05M660K
Current Ratio3.25x3.48x4.94x7.28x6.66x6.17x11.00x14.26x12.56x32.82x60.90x96.85x21.87x25.37x27.18x51.01x4.69x6.08x17.65x7.42x
Quick Ratio3.07x3.28x4.77x7.06x6.51x5.98x10.74x14.04x12.52x32.82x60.90x96.85x21.87x25.37x27.18x51.01x4.69x6.08x17.65x7.42x
Cash Conversion Cycle--52.46159.09134.2548.5971.9693.2-138.89-4.12K-----------
Total Non-Current Liabilities198.54M176.12M176.65M174.25M174.27M75.55M70.72M70.92M00037K92K146K199K3.1M5.52M82.62M4.43M84.53M
Long-Term Debt0171.6M96.52M96.37M949K000000000002.28M3.17M04.93M
Capital Lease Obligations000001.07M0000037K92K146K199K251K300K349K4.43M480K
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities198.54M3.4M79.15M76.75M173.32M73.38M69.38M69.38M00000002.85M2.93M76.12M076.12M
Total Liabilities263.44M236.98M226.26M213.39M225.15M121.15M98.34M94.36M16.62M6.72M3.71M2.43M11.27M10.2M10.04M8.55M13.85M90.08M19.24M92.72M
Total Debt0171.6M96.52M96.37M1.53M1.66M73K42K102K160K217K274K327K379K431K481K6.33M7.25M5.55M9.03M
Net Debt-25.62M163.44M72.2M55.06M-58.02M-49.88M-39.79M-50.77M-39.55M-36.47M-55.79M-70.7M-60.2M-118.64M-87.43M-210.04M-30.99M-37.34M-228.44M-51.03M
Debt / Equity-13.72x1.57x0.84x0.01x0.01x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.24x-0.02x-
Debt / EBITDA-------0.00x------------
Net Debt / EBITDA--------1.07x------------
Interest Coverage-13.39x-24.15x-23.83x-----------------
Total Equity-11.96M12.51M61.31M114.26M147.66M192.32M228.97M256.8M200.98M215.24M223.87M230.76M237.28M248.55M261.15M272.89M25.88M-44.03M293.23M-31.27M
Equity Growth %-108.1%-93.49%-73.22%-55.51%-26.53%-10.65%2.28%11.28%-15.3%-13.4%-14.28%-15.44%816.72%664.48%-10.94%972.7%-92.21%-112.59%-20.44%-
Book Value per Share-0.120.130.621.161.491.962.342.622.072.222.322.402.482.622.772.900.28-0.473.13-0.89
Total Shareholders' Equity-11.96M12.51M61.31M114.26M147.66M192.32M228.97M256.8M200.98M215.24M223.87M230.76M237.28M248.55M261.15M272.89M25.88M-44.03M293.23M-31.27M
Common Stock10K10K10K10K10K10K10K10K10K10K10K10K9K9K9K9K260K260K4K3K
Retained Earnings-453.15M-417.56M-355.22M-294.6M-253.28M-202.13M-157.25M-123.31M-173.24M-154.11M-141.59M-131.3M-124.14M-109.27M-91.9M-76.94M-62.51M-55.93M-210.84M-42.26M
Treasury Stock00000000000000000000
Accumulated OCI-104K-140K-96K125K-7K-46K72K220K339K-145K-124K49K-161K-180K68K407K00-1.25M0
Minority Interest00000000000000000000